DS
IMA

David Shaw’s ImageneBio Inc IMA Stock Holding History

David Shaw’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-999
Closed -$168K – 5071
2021
Q2 		$168K Buy
+999
New +$220K ﹤0.01% 4476

Other funds holding IMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

David Shaw's IMA Position: Q3 2021 in Review

David Shaw sold out of ImageneBio Inc (IMA) in Q3 2021, closing a stake of 999 shares — an estimated $168K sold.

David Shaw first reported a position in IMA in Q2 2021 and held it in 1 quarter. The position peaked at $168K in Q2 2021. 39 funds tracked by Wall St. Rank hold IMA as of Q3 2021.

  • David Shaw reported no remaining ImageneBio Inc position as of Q3 2021 after selling out during the quarter.
  • David Shaw sold 999 ImageneBio Inc shares in Q3 2021, an estimated $168K.
  • David Shaw first reported a position in ImageneBio Inc in Q2 2021 and held it in 1 quarter.
  • David Shaw's ImageneBio Inc position peaked at $168K in Q2 2021.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2021.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.